Ali Yazdanyar, DO, PhD, MMM, MS
Associate Professor of Clinical Medicine (Hospital Medicine)
Associate Scholar, Center for Clinical Epidemiology and Biostatistics
Perelman School of Medicine
Department: Medicine
Contact information
5 Maloney, 5th floor, Ste. 5033
3400 Spruce St.
Philadelphia, PA 19104
3400 Spruce St.
Philadelphia, PA 19104
Office: 215-662-3797
Fax: 215-662-6250
Fax: 215-662-6250
Publications
Links
Search PubMed for articles
Associate Scholar Center for Clinical Epidemiology and Biostatistics
Search PubMed for articles
Associate Scholar Center for Clinical Epidemiology and Biostatistics
Education:
BS (Biological Sciences, Minor in Health Studies)
Pennsylvania State University, State College, PA, 1997.
DO
Des Moines University, Des Moines, IA, 2001.
MMM (Master of Medical Management)
Carnegie Mellon University, Pittsburgh, PA, 2011.
PhD (Epidemiology)
University of Pittsburgh, Pittsburgh, PA, 2011.
MS (Applied Statistics)
University of Delaware, Newark, DE, 2020.
Permanent linkBS (Biological Sciences, Minor in Health Studies)
Pennsylvania State University, State College, PA, 1997.
DO
Des Moines University, Des Moines, IA, 2001.
MMM (Master of Medical Management)
Carnegie Mellon University, Pittsburgh, PA, 2011.
PhD (Epidemiology)
University of Pittsburgh, Pittsburgh, PA, 2011.
MS (Applied Statistics)
University of Delaware, Newark, DE, 2020.
Selected Publications
Nelson BD, McLaughlin CJ, Rivera OE, Kaul K, Ferdock AJ, Matuzsan ZM, Yazdanyar AR, Gopal JV, Patel AY, Chaska RM, Feldman BA, Jacoby JL. : Implementation of a Novel Prehospital Clinical Decision Tool and ECG Transmission for STEMI Significantly Reduces Door-to-Balloon Time and Sex-Based Disparities. Prehosp Emerg Care 24: 1-7, Jun 2024.Ali Yazdanyar: Garnering Insight from Claims-Based Databases on the Association between Loop Diuretics and Heart Failure Outcomes. American Journal of Cardiology 2024.
Ward MM, Madanchi N, Yazdanyar A, Shah NR, Constantinescu F. : Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review. Arthritis Res Ther. 25(1): 222, Nov 2023.
Awan RU, Iyer A, Khan UA, Majeed H, Nabeel A, Zaidi SH, Sheikh AB, Shahjahan RD, Yazdanyar A, Sagheer S. : Insights Into Clinical Outcomes of Acute Pancreatitis With Concomitant Acute Myocardial Infarction Using the National Inpatient Sample Database. Am J Cardiol. 203: 295-300, Sep 2023.
Lo KB, Essa H, Wattoo A, Gulab A, Akhtar H, Sudani HA, Angelim L, Helfman B, Peterson E, Brousas S, Whybrow-Huppatz I, Yazdanyar A, Sankaranarayanan R, Rangaswami J.: Representation of Chronic Kidney Disease in Randomized Controlled Trials Among Patients With Heart failure With Reduced Ejection Fraction: A Systematic Review. Curr Probl Cardiol 48(3), Mar 2023.
Yazdanyar A, Vojtek A, Gupta S, Iyer A, Kears AC, Musco K, Li S, Jarjous S.: Association between inpatient palliative care encounter and 30-day all-cause readmissions after index hospitalization for chronic obstructive pulmonary disease. Heart Lung 58: 69-73, Mar-Apr 2023.
Yazdanyar A, Lo KB, Pelayo J, Sanon J, Romero A, Quintero E, Ahluwalia A, Gupta S, Sankaranarayanan R, Mathew R, Rangaswami J.: Association Between Cirrhosis and 30-Day Rehospitalization After Index Hospitalization for Heart Failure. Curr Probl Cardiol 47(10): 100993, Oct 2022.
Yazdanyar A, Guthier D, Maitz T, Singh S, Parfianowicz D, Li S, Jarjous S.: Inpatient palliative care encounter and 30-day readmission among hospitalizations for heart failure. Future Cardiol 18(10): 809-816, Sep 2022.
Yazdanyar A, Greenberg MR, Chen Z, Li S, Greenberg MR, Buonanno AP, Burmeister DB, Jarjous S.: A customized early warning score enhanced emergency department patient flow process and clinical outcomes in a COVID-19 pandemic. J Am Coll Emerg Physicians Open 3(4): e12783, Jul 2022.
Yazdanyar A, Donato A, Wasko MC, Ward MM.: Risk of 30-day Readmission After Knee or Hip Replacement in Rheumatoid Arthritis and Osteoarthritis by Non-Medicare and Medicare Payer Status. J Rheumatol 49(2): 205-212, Feb 2022.